SPAC Overview
$200M
IPO Size
$247M
Trust (as of 2026-06-30)
IPO
Current Status
2024
IPO Year
Timeline Progress
About
A blank-check company seeking an unidentified initial business combination, with a stated focus on healthcare services and healthcare technology.
Investment Focus
Healthcare
Geographic Focus
United States
The terms and the filing trail behind Jackson Acquisition Co II
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Richard Lee Jackson
Chairman of the Board of Directors, Chief Executive Officer, Director
David Lawrence
Chief Financial Officer
Brian Anthony Mccarthy
Director, Director Nominee
J. Nicholas Ayers
Director, Director Nominee
Paul G. Gabos
Director, Director Nominee
Stephan Rodgers
Director, Director Nominee
Nicholas Ayers
Beneficial owner
Stephen S. Rodgers
Underwriters
Extended Team Information
Richard L. Jackson has healthcare entrepreneurship, operations, acquisition, and investment experience; David Lawrence has biotechnology financial and operational leadership experience. Proposed independent directors bring healthcare investment banking and healthcare operating experience.
Stock Performance
JACS.U
Trading Symbol
First Trade
December 11, 2024
$10.02
Current Price
September 30, 2026
$10.78
+8%
Key Information
IPO Date
December 11, 2024
SIC
6770
SPAC Ticker
JACS